Comparative Relaxing Effects of Sildenafil, Vardenafil, and Tadalafil in Human Corpus Cavernosum: Contribution of Endogenous Nitric Oxide Release

Urology

Volumn 74, Issue 1, 2009, Pages 216-221

  Toque, Haroldo A ^a   Priviero, Fernanda B M ^a   Teixeira, Cleber E ^a   Claudino, Mário A ^a   Baracat, Juliana S ^a   Fregonesi, Adriano ^a   De Nucci, Gilberto ^a   Antunes, Edson ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ARGININE METHYL ESTER; GLYCERYL TRINITRATE; GUANYLATE CYCLASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; QUINOXALINE DERIVATIVE; SILDENAFIL; TADALAFIL; VARDENAFIL;

ADOLESCENT; ADULT; AGED; ARTICLE; CITRIC ACID CYCLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; DRUG RESPONSE; ELECTRIC FIELD; ELECTROSTIMULATION; FORCE TRANSDUCER; HUMAN; HUMAN TISSUE; MALE; MUSCLE CONTRACTION; MUSCLE ISOMETRIC CONTRACTION; PENIS ERECTION; PRIORITY JOURNAL; SMOOTH MUSCLE; SMOOTH MUSCLE RELAXATION;

ADOLESCENT; ADULT; AGED; CARBOLINES; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; MUSCLE RELAXATION; NITRIC OXIDE; PENIS; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; SULFONES; TRIAZINES; YOUNG ADULT;

EID: 67649197660     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.12.056     Document Type: Article

References (29)

1. Andersson K.E. Pharmacology of penile erection. Pharmacol Rev 53 (2001) 417-450
2. Dean R.C., and Lue T.F. Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin North Am 32 (2005) 379-395
3. Rybalkin S.D., Yan C., Bornfeldt K.E., et al. Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circul Res 93 (2003) 280-291
4. Omori K., and Kotera J. Overview of PDEs and their regulation. Circul Res 100 (2007) 309-327
5. Ballard S.A., Gingell C.J., Tang K., et al. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 159 (1998) 2164-2171
6. Wallis R.M., Corbin J.D., Francis S.H., et al. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function and the contractile responses of trabeculae carneae and aortic rings in vitro. Am J Cardiol 83 (1999) 3C-12C
7. Corbin J.D., Beasley A., Blount M.A., et al. Vardenafil: Structural basis for higher potency over sildenafil in inhibiting cGMP-specific phosphodiesterase-5 (PDE5). Neurochem Int 45 (2004) 859-863
8. Giuliano F., Bernabe J., Alexandre L., et al. Pro-erectile effect of vardenafil: in-vitro experiments in rabbits and in-vivo comparison with sildenafil in rats. Eur Urol 44 (2003) 731-736
9. Uckert S., Hedlund P., Waldkirch E., et al. Interactions between cGMP- and cAMP-pathways are involved in the regulation of penile smooth muscle tone. World J Urol 22 (2004) 261-266
10. Lau L.C., and Adaikan P.G. Mechanisms of direct relaxant effect of sildenafil, tadalafil and vardenafil on corpus cavernosum. Eur J Pharmacol 541 (2006) 184-190
11. Flores-Toque H.A., Priviero F.B., Teixeira C.E., et al. Synthesis and pharmacological evaluations of sildenafil analogues for treatment of erectile dysfunction. JMC 51 (2008) 2807-2815
12. Hallén K., Wiklund N.P., and Gustafsson L.E. Inhibitors of phosphodiesterase 5 (PDE5) inhibit the nerve-induced release of nitric oxide from the rabbit corpus cavernosum. Br J Pharmacol 150 (2007) 353-360
13. Doherty P.C., Bivalacqua T.J., Champion H.C., et al. Direct effects of selective type 5 phosphodiesterase inhibitors alone or with other vasodilators on the erectile response in cats. J Urol 165 (2001) 1004-1009
14. McAuley I.W., Kim N.N., Min K., et al. Intracavernosal sildenafil facilitates penile erection independent of the nitric oxide pathway. J Androl 22 (2001) 623-628
15. Bischoff E. Vardenafil preclinical trial data: potency, pharmacodynamics, pharmacokinetics, and adverse events. Int J Impot Res 16 suppl 1 (2004) S34-S37
16. Blount M.A., Beasley A., Zoraghi R., et al. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation. Mol Pharmacol 66 (2004) 144-152
17. Gbekor E., Betheil S., Fawcett L., et al. Selectivity of sildenafil and other phosphodiesterases type 5 (PDE5) inhibitors against all human phosphodiesterase families. Eur Urol 1 suppl (2002) 63
18. Tinel H., Stelte-Ludwig B., Hütter J., et al. Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms. BJU Int 98 (2006) 1259-1263
19. Teixeira C.E., Priviero F.B., and Webb R.C. Differential effects of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, and tadalafil in rat aorta. J Pharmacol Exp Ther 316 (2006) 654-661
20. Toque H.A., Teixeira C.E., Priviero F.B., et al. Vardenafil, but not sildenafil or tadalafil, has calcium-channel blocking activity in rabbit isolated pulmonary artery and human washed platelets. Br J Pharmacol 154 (2008) 787-796
21. Mehrotra N., Gupta M., Kovar A., et al. The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy. Int J Impot Res 19 (2007) 253-264
22. Sakuma I., Akaishi Y., Tomioka H., et al. Interactions of sildenafil with various coronary vasodilators in isolated porcine coronary artery. Eur J Pharmacol 437 (2002) 155-163
23. Palea S., and Barras M. Comparison of the relaxant effects of alfuzosin, phentolamine and sildenafil on rabbit isolated corpus cavernosum. BJU Int 91 (2003) 873-877
24. Aydin S., Ozbek H., Yilmaz Y., et al. Effects of sildenafil citrate, acetylcholine, and sodium nitroprusside on the relaxation of rabbit cavernosal tissue in vitro. Urology 58 (2001) 119-124
25. Thompson C.S., Mumtaz F.H., Khan M.A., et al. The effect of sildenafil on corpus cavernosal smooth muscle relaxation and cyclic GMP formation in the diabetic rabbit. Eur J Pharmacol 425 (2001) 57-64
26. Behr-Roussel D., Gorny D., Mevel K., et al. Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: lack of tachyphylaxis. Eur Urol 47 (2005) 87-91
27. Gibson A. Phosphodiesterase 5 inhibitors and nitrergic transmission: from zaprinast to sildenafil. Eur J Pharmacol 411 (2001) 1-10
28. Simonsen U., Contreras J., Garcia-Sacristán A., et al. Effect of sildenafil on non-adrenergic non-cholinergic neurotransmission in bovine penile small arteries. Eur J Pharmacol 412 (2001) 155-169
29. Sharabi F.M., Daabees T.T., El-Metwally M.A., et al. Comparative effects of sildenafil, phentolamine, yohimbine and L-arginine on the rabbit corpus cavernosum. Fundam Clin Pharmacol 18 (2004) 187-194